Acosta Opens New Growth Channel for Manufacturers Through Salvatori-Scott Partnership

As health and wellness brands look beyond traditional retail for growth, the independent drug channel is emerging as an increasingly important opportunity. To help manufacturers capitalize on that shift, Acosta has partnered with Salvatori-Scott Inc. (SSI), combining national retail capabilities with specialized expertise in independent pharmacy and health care channels.

For manufacturers, the result is a more connected way to reach one of retail's most specialized markets. The partnership brings together national sales coverage, retail execution, analytics and omnichannel capabilities with decades of independent drug expertise, helping brands strengthen distribution while expanding opportunities across managed care organizations, Medicare Advantage programs, group purchasing organizations, hospitals and long-term care providers.

"Manufacturers have been asking for a simpler way to reach the independent drug channel without sacrificing the scale and capabilities they need across the rest of retail," said Denise Wellander, senior vice president of Drug and Value at Acosta. "Rather than spending years building those capabilities ourselves, we chose to partner with the company that has already earned the trust and relationships throughout this space. Together, we're making it easier for clients to pursue growth opportunities that were previously much harder to access."

The partnership reflects Acosta's continued investment in strategic growth areas where retail and health care increasingly intersect. It also creates new opportunities for SSI to extend its specialized expertise to manufacturers seeking broader, multi-channel solutions backed by Acosta's national scale.